Skip to Content

  Resources Hub.

DispenCell provides robust results for cell line development

In collaboration with Mural Oncology, Waltham, USA. June, 2024.

Discover more

Industrial Validation of Automated Single-Cell Cloning with DispenCell ​

In collaboration with Biotech Process Sciences, Merck Biopharma, Corsier-sur-Vevey, Switzerland. Oct, 2021.

Discover more

Double Assurance of Clonality with DispenCell and OMNI

In collaboration with Axio Biosystems. Feb, 2025.

Continue reading

Single-Cell Cloning of Human iPSCs with Dual Monoclonality Check

In collaboration with Molecular Devices. Feb, 2024.

Continue reading

Standardized Mini-Spheroids for High-Throughput Screening

In collaboration with LiveDrop. Aug, 2024.

Continue reading

High-Precision Spheroid Seeding with Dispen3D and AggreWell

Experiment conducted by SEED Biosciences. Oct, 2024.

Discover more